Latest News
From the Journals
British good practice paper offers MCL diagnosis pearls
The good practice paper includes new information on pathology and use of PET/CT scanning in staging of disease.
News
FDA database reveals many rheumatic and musculoskeletal adverse events on immunotherapies
AMSTERDAM –
Latest News
New NIH consortium aims to coordinate pediatric research programs
The organization will harmonize activities, set priorities, explore gaps, and find opportunities in NIH’s pediatric research.
From the Journals
RBC transfusions with surgery may increase VTE risk
Stricter blood management practices and VTE prophylaxis may be needed if the study findings are confirmed.
Feature
Most Medicaid enrollees exempt from work requirements
States’ online reporting systems represent potential barrier to many recipients.
News
FDA approves pembrolizumab for relapsed/refractory PMBCL
The FDA granted accelerated approval based on results from the KEYNOTE-170 trial.
News
FDA approves bevacizumab for advanced ovarian cancer
Approval was based on improved PFS for bevacizumab in combination with chemo followed by use as monotherapy in stage III and IV patients.
From the Journals
Protein activation could predict renal cell carcinoma recurrence
The activation level of the 4EBP1/eIF4E axis may help predict if and when a patient with renal cell carcinoma is likely to experience a recurrence...
From the Editor
Seeking the chair
Dr. Matt Kalaycio decodes the qualities it takes to be a department chairperson.
Conference Coverage
PREOPANC-1: Early findings suggest benefit with preop chemo in pancreatic cancer
Preliminary findings from the PREOPANC-1 trial suggest preoperative chemotherapy improves outcomes in pancreatic cancer patients.
News
FDA approves pembrolizumab for cervical cancer
Pembrolizumab is the first anti-PD-1 therapy approved for the treatment of advanced cervical cancer.